NewsBlazeAU – Lifestyle
Author:
Pliant Therapeutics, Inc.
Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
April 18, 2026
Pliant Therapeutics Announces Upcoming Presentation of Phase 1 Clinical Trial of PLN-101095 in Patients with Solid Tumors at the 2026 AACR Annual Meeting
March 18, 2026
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2025 Financial Results
March 11, 2026